Rock Springs Capital LLC 3
3 · Homology Medicines, Inc. · Filed Mar 27, 2018
Insider Transaction Report
Form 3
Rock Springs Capital Management LP
10% Owner
Holdings
- (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (395,845 underlying)
Footnotes (2)
- [F1]The preferred stock is convertible into the Issuer's common stock on a one-for-one basis at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.
- [F2]The securities reported herein are held of record by Rock Springs Capital Master Fund LP ("Master Fund"). Rock Springs Capital LLC ("RSC") is the general partner of Rock Springs Capital Management LP ("RSCM") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the Series B Preferred Stock held directly by Master Fund.